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ABSTRACT  40 
Background  Recent evidence has highlighted the prevalence of mild-to-moderate iodine deficiency 41 
in women of childbearing age and pregnant women, with important public health ramifications owing 42 
to the role of iodine, required for thyroid hormone production, in neurodevelopment. Cow’s milk 43 
contributes the greatest amount to iodine intakes in several countries. 44 
Objective The objective of this study was to investigate the effect of increased cow’s milk 45 
consumption on iodine status, thyroid hormone concentrations and selenium status. 46 
Methods A 12 week, randomized-controlled trial was conducted in 78 low-moderate milk consuming 47 
(<250ml/d) healthy women (18-45 years). The intervention group were asked to consume 3L of semi-48 
skimmed milk per week, while the control group continued their usual milk consumption (baseline 49 
median (IQR): 140 (40-240) mL/d). At baseline, week 6 and week 12 participants provided a spot-50 
urine sample [urinary iodine concentration (UIC); creatinine] and a fasting blood sample [thyroid 51 
hormone concentrations; serum total selenium; selenoprotein P]. This study was registered at 52 
ClinicalTrials.gov Study (Ref: NCT02767167). 53 
Results At baseline, the median (IQR) UIC of all participants was 78.5 (39.1-126.1)µg/L. Changes in 54 
the median UIC from baseline to week 6 (35.4 vs. 0.6 µg/L; P=0.014) and week 12 (51.6 vs. -3.8 55 
µg/L; P=0.045) were significantly greater in the intervention group compared with the control group. 56 
However, despite being higher within the intervention group at weeks 6 and 12, the change in the 57 
iodine:creatinine ratio from baseline was not significantly different between groups  at either week 6 58 
(P=0.637) or 12 (P=0.178). There were no significant differences in thyroid hormone concentrations 59 
or selenium status between groups at any time point. 60 
Conclusions The present study has demonstrated that the consumption of additional cow’s milk can 61 
significantly increase UIC in women of childbearing age. These results suggest that cow’s milk is a 62 
potentially important dietary source of iodine in this population group. 63 
KEYWORDS: Iodine; women of childbearing age; milk; randomized-controlled trial; iodine 64 
deficiency; selenium 65 
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INTRODUCTION  66 
Iodine is an essential micronutrient required for the production of the thyroid hormones, 67 
triiodothyonine (T3) and thyroxine (T4), which are critical for human growth and neurodevelopment 68 
[1, 2]. Selenium is required for the conversion of T4 to the metabolically active T3 hormone and is 69 
thus considered a co-nutrient in the study of thyroid function [3]. Iodine requirements are greater in 70 
pregnancy owing to an increased rate of thyroid hormone synthesis, renal clearance and iodine 71 
transfer to the fetus [4, 5]. The consequences of poor iodine status during pregnancy range from 72 
reduced education [6] and intelligence quotient (IQ) [7], observed with mild deficiency, to the 73 
irreversible mental retardation of  cretinism linked with severe deficiency [8, 9]. The World Health 74 
Organization (WHO) therefore recommends 250µg/d for pregnant and breastfeeding women and the 75 
recommended nutrient intake (RNI) for adults, including women of childbearing age, is 150µg/d [10].  76 
 77 
Urinary iodine concentration (UIC) is measured to assess iodine nutrition in a population with up to 78 
90% of dietary iodine excreted in the urine. A median UIC of less than 100µg/L in the general 79 
population is indicative of iodine deficiency [10], whilst in pregnancy a median UIC below 150 µg/L 80 
indicates deficiency in the group [10]. Ensuring women enter pregnancy with sufficient iodine stores 81 
in the thyroid is an issue of significant public health importance. Yet deficiency remains a concern 82 
worldwide and there are numerous reports of insufficient iodine status (UIC ≤100µg/L) amongst 83 
women of childbearing age in industrialized countries, including the US where iodized salt is 84 
available [11-15].  85 
 86 
Milk and dairy foods provide the greatest contribution to total dietary iodine intakes in the US, 87 
Denmark, Norway, the UK and Ireland [16-20], with milk contributing 33% of total intakes in the 88 
UK adult population [21]. It has been suggested that a general decline in milk consumption in the UK 89 
may be contributing to the increased prevalence of mild-to-moderate iodine deficiency observed there 90 
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in recent years [12, 22, 23]. Observational evidence has consistently shown milk consumption to be 91 
positively associated with iodine intake and status, including in the US [11, 24-28]. However, no 92 
randomized-controlled trial has yet examined the effect of pasteurized cow’s milk consumption on 93 
iodine status. The possibility of increasing iodine intake by increasing milk consumption, an 94 
inexpensive and widely-available foodstuff, in a population group vulnerable to iodine deficiency is 95 
warranted.  96 
 97 
The primary aim of this study was to investigate the effect of increased cow’s milk consumption on 98 
iodine status, as measured by UIC. The secondary aims were to investigate the effect of milk 99 
consumption on thyroid hormone concentrations and selenium status. 100 
 101 
METHODS 102 
Subjects and study design 103 
The study was a 12 week, randomized controlled dietary intervention in 78 healthy women of 104 
childbearing age conducted at Ulster University, Coleraine between July and December 2015. 105 
Recruitment targeted females aged between 18 and 45 years, whose milk consumption was reported 106 
to be habitually low-moderate (consumption of ≤250ml of milk per day). Exclusion criteria included 107 
smokers, those with a history of thyroid or gastrointestinal conditions, use of thyroid medication, 108 
lactose intolerance, milk allergy, non-milk consumption, vegan diet and those consuming dietary 109 
supplements containing iodine or selenium within the 3 months prior to the study. Further exclusion 110 
criteria included women who were pregnant, breastfeeding or planning to become pregnant during 111 
the study and those who were deemed peri- or post-menopausal. Written informed consent was 112 
obtained from eligible participants. The present study was conducted according to the guidelines laid 113 
down in the Declaration of Helsinki, and all procedures involving human subjects were approved by 114 
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the Ulster University Research Ethics Committee (Ref: REC/15/0042). The study was registered on 115 
ClinicalTrials.gov (Ref: NCT02767167).  116 
 117 
The a priori sample size was calculated using GPower version 3.1 [29] with UIC as the primary 118 
outcome between groups. A total sample size of 70 was required to detect (or not) an increase of 30% 119 
from a population median of UIC (80.1µg/L); changing iodine status from inadequate to sufficient 120 
(α=0.05, β=0.80, effect size=0.30) [26]. A further 10% was added to account for study attrition. 121 
 122 
An independent clinical trials manager randomly allocated eligible participants to intervention or 123 
control group using MINIM randomization software [30]. Randomisation was stratified by median 124 
baseline milk consumption (< or > the median intake of 120mL/d) with an allocation ratio of 1:1 to 125 
ensure groups were balanced with respect to their habitual milk consumption. Participants in the 126 
intervention group were provided with 3 L of pasteurized semi-skimmed milk weekly and were 127 
required to consume this evenly across the week (approximately 430mL/d) as they wished (i.e. as a 128 
glass of milk, in a milkshake, or in tea or coffee), whilst continuing with their usual dietary habits and 129 
lifestyle. Prior to the analysis of milk used in the intervention study, it was anticipated that 130 
consumption of 430mL/d of intervention milk would provide an additional 133µg/d iodine (92% of 131 
the UK RNI (140µg/d) [31] based on an expected milk iodine concentration of 310µg/L [32]. Those 132 
in the control group were not provided with additional milk and were asked to continue with their 133 
usual milk consumption, dietary habits and lifestyle. Milk used in the intervention was purchased at 134 
retail and was therefore of similar composition to that habitually consumed by participants prior to 135 
intervention, and by the control group, throughout the intervention period. Each participant completed 136 
an appointment at baseline (week 0), week 6 and week 12 when anthropometric measurements, 137 
dietary intake data, urine and blood samples were collected.  138 
 139 
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Blood & urine samples 140 
Participants provided a non-fasted 10 ml spot-urine morning sample at weeks 0, 6 and 12. Samples 141 
were collected in sterile tubes free from preservatives. Aliquots of each sample were taken and 142 
samples were stored at -80°C until batch analysis at the end of the study. A 30ml fasting blood sample 143 
was collected at weeks 0, 6 and 12 by a trained phlebotomist. Blood samples were processed within 144 
4 hours of collection. Serum aliquots were obtained by centrifuging whole blood at 1370 x g for 15 145 
minutes at 4°C. Prepared aliquots were stored at -80°C until batch analysis at the end of the study. 146 
 147 
Anthropometric measurements 148 
Standing height (cm) was measured to the closest 0.1cm at baseline using a calibrated stadiometer 149 
(SECA, Hamburg, Germany). Weight (kg) was measured to the nearest 0.1kg without heavy clothing 150 
or footwear at each time point using calibrated scales (SECA, Brosch Direct Ltd, Peterborough, UK). 151 
Body mass index (BMI) was calculated as weight (kg) / height2 (m2). All measurements were made 152 
by the same researcher using the same equipment across all time points.  153 
 154 
Dietary intake 155 
At each time point, participants completed a 24hr dietary recall which was analyzed using Nutritics 156 
(Dublin, Ireland). The 24hr dietary recalls were used to estimate milk intakes in order to assess 157 
compliance with the intervention.  158 
 159 
Biochemical measurements 160 
UIC was measured in spot-samples by Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) at 161 
University Hospital Southampton [7].  Iodine status of the group was classified according to WHO 162 
criteria, where a median UIC of <100µg/L indicates risk of iodine deficiency [10]. All samples were 163 
measured in duplicate and the accuracy of results was verified with a certified reference material 164 
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(Seronorm Level 1 and Level 2, Sero, Norway). Urinary creatinine (Cr) concentration was also 165 
measured at University Hospital Southampton by the Jaffe rate method [7,33]. The iodine-to-166 
creatinine ratio was calculated to adjust for intra-individual variation in urine volume [10, 34, 35]. 167 
Serum thyroid hormone concentrations were measured to assess thyroid function. Free concentrations 168 
of T3 (FT3), T4 (FT4) and TSH were analyzed using a Roche Cobas 8000 modular analyzer 169 
(Biochemistry Laboratory, Northern Health and Social Care Trust, Antrim).  Normal reference values 170 
used were as follows: thyroid stimulating hormone (TSH), 0.27–4.2mIU/L; FT3, 3.5–6.8nmol/L; 171 
FT4, 12.0–22.0pmol/L [36]. 172 
Two markers of selenium status were measured by the Charité-Universitätsmedizin Berlin. Serum 173 
total selenium concentrations were measured by X-ray fluorescence, using a bench-top total reflection 174 
X-ray fluorescence (TXRF) spectrometer (PicofoxS2, Bruker Nano GmbH, Berlin). For the purposes 175 
of this study, inadequate selenium status was classified as those with a serum selenium concentration 176 
of <70µg/L [37]. We also measured concentrations of serum selenoprotein P (SELENOP), a 177 
functional measure of selenium status [38], by a sandwich assay (Selenotest, ICI GmbH, Berlin, 178 
Germany).  179 
 180 
Milk analysis 181 
Weekly samples of the intervention milk (n= 21) were collected and stored at -20oC until their 182 
analysis for iodine and selenium concentrations by LGC Limited (Teddington, Middlesex, UK). For 183 
selenium determination, samples were microwave-digested with nitric acid [39] and for iodine 184 
determination, samples were oven-digested with tetramethylammonium hydroxide (TMAH) prior to 185 
their transport to LGC Limited [39]. Samples were analyzed by inductively coupled plasma MS 186 
(Element2; ThermoFisher Scientific, Bremem, Germany) as described previously [40]. The 187 
uncertainty of the method for iodine and selenium analysis was calculated as ±10% and ±15% 188 
respectively using International Organisation for Standardisation (ISO) 17 025 methodology. 189 
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Accuracy of the results was verified using a certified reference material (ERM-BD150; LGC 190 
Standards, Teddington, UK).  191 
 192 
Statistical analysis 193 
Statistical analysis was undertaken using Statistical Package for Social Sciences (SPSS) for Windows 194 
(Version 22.0; IBS SPSS Statistics). Results reported are based on intention-to-treat (last observation 195 
carried forward) analysis. Normality was assessed using the Kolmogorov-Smirnov test. The UIC, 196 
iodine:creatinine and SELENOP data were not normally distributed and therefore we reported 197 
medians and the IQR. Differences between groups were assessed using Independent T-tests for 198 
parametric data or Mann-Whitney U-tests for non-parametric data. We used the Wilcoxon Signed 199 
Rank Test to examine changes within each group over the intervention. To compare the proportion 200 
of participants with low iodine or selenium status (UIC <100µg/L; selenium <70µg/L) between 201 
groups the Fishers’ Exact test was used due to small numbers in each group. The one-way ANOVA 202 
test was used to test changes in the iodine and selenium concentrations in milk samples over the 203 
intervention period. Spearman rank correlations were used to explore the relationship between milk 204 
intake and iodine status. A P-value of <0.05 was considered statistically significant throughout.  205 
 206 
RESULTS 207 
An overview of the recruitment and flow of participants through the study, according to CONSORT 208 
guidelines [41], is outlined in Figure 1. Of the 78 participants who were recruited, five withdrew (n= 209 
2 intervention group; n= 3 control group). Intention to treat analysis was conducted for all 78 210 
participants. There were no differences in any characteristic at baseline for participants who withdrew 211 
from the study and those who completed the study. Baseline characteristics of intervention (n= 39) 212 
and control (n= 39) participants are shown in Table 1. The median (IQR) age of participants at 213 
baseline was 26.5 (21.8-33.0) years. There were no significant differences with respect to any subject 214 
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characteristic, including UIC (P=0.393), iodine:creatinine ratio (P=0.842) and daily milk 215 
consumption (P=0.539), between the intervention and control groups at baseline. Using data from the 216 
24hr dietary recall, median (IQR) daily milk intakes were estimated to be 140mL/d (40- 240), 217 
130mL/d (80- 240) and 120mL/d (80- 225) in the control group at weeks 0, 6 and 12 respectively. In 218 
comparison, the intervention group consumed an estimated 120mL/d (40- 200), 340mL/d (120- 425) 219 
and 260mL/d (150- 420) at weeks 0, 6 and 12 respectively.  220 
   221 
Iodine status 222 
UIC was significantly higher in the intervention group after weeks 6 and 12 compared to the control 223 
group (P=0.005 and P=0.026 respectively) (Table 2). Changes in UIC from baseline to weeks 6 224 
(median: 35.4 vs. 0.6µg/L, P=0.014) and 12 (51.6 vs. -3.8µg/L, P=0.045) were also significantly 225 
greater in the intervention compared to the control group. The iodine:creatinine ratio was higher in 226 
the intervention group than the control group at weeks 6 (P=0.10) and 12 (P=0.14), but these 227 
differences were not significant. However, the change in iodine:creatinine from baseline to week 6 228 
was almost significantly higher in the intervention compared to the control group (36.7 vs. -4.0µg/L, 229 
P=0.061). Within the intervention group, both UIC and iodine:creatinine were significantly greater 230 
at weeks 6 (UIC P=0.02; iodine:creatinine P=0.01) and 12 when compared to baseline (UIC P=0.007; 231 
iodine:creatinine P=0.004). However there were no significant differences in either UIC or 232 
iodine:creatinine within the control group when baseline values were compared to week 6 (UIC 233 
P=0.84; iodine:creatinine P=0.94). When baseline values were compared to week 12 there was no 234 
significant difference in UIC within the control group (P=0.49) and although, there appeared to be 235 
greater iodine:creatinine ratio, this was non-significant (P=0.11).  At baseline, 62% of participants in 236 
the intervention group had a UIC <100µg/L which significantly reduced to 38% following the 237 
intervention (P=0.042). There was no significant change in the proportion of participants with UIC 238 
<100µg/L in the control group between baseline (62%) and week 12 (61%) (P =0.838).  239 
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 240 
For all participants, reported milk intake was significantly positively associated with the 241 
iodine:creatinine ratio at baseline (=0.27; P=0.018) and non-significantly associated with the UIC 242 
(=0.19; P=0.09). Following the intervention, the positive association between iodine:creatinine and 243 
reported milk intake remained significant for the intervention group (=0.464; P=0.004) but not for 244 
the control group (=0.311; P=0.06). At baseline, those participants with a reported milk intake above 245 
the median (>120ml/d) had a significantly higher urinary iodine:creatinine ratio (median (IQR): 91.4 246 
(67.2-117) vs. 70.4 (54.7-110)µg/g; P=0.04), with no association with the UIC (72.2 (29.6-111) vs. 247 
91.8 (39.6-149) (P=0.184), when compared to those with lower milk intake (≤120mL/d). Reported 248 
milk consumption in the intervention group at week 6 was 340mL/d and at week 12, 260mL/d, but 249 
there was no significant difference between time points (P=0.791). 250 
 251 
Thyroid hormones and selenium status 252 
At baseline, 97% (n= 76), 100% and 96% (n= 75) of participants had a TSH, FT4 and FT3 253 
concentrations within the normal range, respectively. The milk intervention had no effect on any 254 
thyroid hormone parameter, with no significant differences in TSH (P=0.478), FT3 (P=0.938) or FT4 255 
(P=0.921) between groups at week 12. (Table 2). Neither was there a significant difference between 256 
groups in serum selenium (P=0.934) or SELENOP concentrations (P=0.540) at week 12 (Table 3).  257 
 258 
The mean serum selenium concentration in all groups at baseline was 77.9µg/L and 27% (n= 21) of 259 
participants had inadequate selenium status (<70µg/L). Of these participants, 17% also had a UIC 260 
<100µg/L. There were no significant differences between groups in the proportion of participants 261 
with a low serum selenium status (<70µg/L) at baseline (P=0.31) or at study completion (P=0.80).  262 
 263 
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Iodine and selenium composition of milk 264 
The median (IQR) iodine concentration of intervention milk was 746 (715-790)µg/L and the median 265 
(IQR) selenium concentration of intervention milk was 19.9 (18.6-21.1)µg/L. There was no 266 
significant difference in the iodine (P= 0.15) or selenium concentration of intervention milk when 267 
compared across month of collection (P= 0.22) (Supplemental Table 1).  268 
 269 
DISCUSSION 270 
To the authors’ knowledge, this is the first randomized-controlled trial to investigate the effect of 271 
cow’s milk consumption on iodine status. Results show that, following the provision of an additional 272 
3L/wk, an increased daily consumption of cow’s milk significantly increased UIC compared to the 273 
control group who maintained their habitual low-moderate intake of milk. The women of childbearing 274 
age in our cohort were classed as mildly iodine deficient at baseline according to their median UIC 275 
of 78.5 (39.1-126)µg/L. Previous studies have also reported iodine deficiency amongst women of 276 
childbearing age in the UK and Ireland [11, 42, 43]. However data from the recent National Diet and 277 
Nutrition Survey (NDNS) suggest that, as a whole, UK women of childbearing age (16 – 49 years) 278 
have adequate iodine status with a median (20th, 80th percentile) UIC of 117 (65, 198)µg/L [44].  279 
Despite offering population-wide data, based on just one spot urine sample the NDNS data cannot 280 
reliably inform on the prevalence of deficiency in this subgroup and it has been noted that dietary 281 
data, collected in the same survey, do not support the suggestion of adequate iodine nutrition [44, 45]. 282 
It is therefore possible that a considerable proportion of women in the UK may potentially enter 283 
pregnancy with low iodine stores [45]. This is particularly worrisome as recent research has shown 284 
that even mild-to-moderate iodine deficiency during pregnancy is associated with lower IQ and 285 
reading ability of children aged 8 – 9 years [7]. In the US, where salt iodization is mandatory and 286 
population UIC has been monitored since 1971, women of childbearing age are in general thought to 287 
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have sufficient iodine status [46, 47].  However fluctuations have been noted over the years and 288 
attributed to changes in agricultural practices affecting iodine concentrations of the milk [15, 48]. 289 
 290 
The present intervention was shown to significantly increase median UIC from week 0 to week 12 in 291 
the intervention group and to increase the iodine:creatinine ratio, albeit non-significantly (P>0.05). 292 
Similar increases in iodine status have been achieved in a two-week encapsulated seaweed 293 
intervention study in a group of women aged 18-50 years [43]. Although seaweed is a source of 294 
iodine, its content is highly variable and there is concern that consumption of seaweed in large 295 
amounts may lead to intakes above the tolerable upper limit (TUL) [49, 50]. Furthermore, iodized 296 
salt is not widely available in countries where salt iodization is not mandatory, such as the UK [51] 297 
and therefore is unlikely to provide a reliable source of iodine to vulnerable groups. Previous research 298 
in the US has indicated that the iodine concentration of dietary supplements is highly variable (range: 299 
0-300µg/d) [52, 53] and that there is a low consumption of iodine-containing supplements among 300 
women of childbearing age [54-56]. Milk is therefore the most important source of iodine in many 301 
countries [16, 17, 19, 44], and the current study shows that increasing milk consumption is an 302 
effective way of increasing iodine intake as assessed by UIC. We have previously reported that 303 
women of childbearing age have poor knowledge of the dietary sources of iodine [57]. Therefore 304 
public-health strategies to address iodine deficiency could focus on educating young women on the 305 
importance of receiving adequate iodine pre-conception and on raising awareness of cow’s milk as a 306 
significant dietary source.  307 
 308 
It is estimated that 6 billion people worldwide consume milk and although consumption is higher in 309 
developed countries, the gap with developing countries is narrowing [578]. The latest dietary survey 310 
data on the UK population data show that 73% of women (aged 19- 64 years) are consumers of semi-311 
skimmed milk with a median intake of 95g/d [44]. In general, figures show milk consumption is on 312 
the decline, particularly amongst young girls and teenagers who are the most vulnerable to the 313 
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consequences of iodine deficiency [59]. One reason may be that this age group perceive milk to be a 314 
high-fat food. Conducting qualitative research could provide further insight into the potential barriers 315 
to increasing milk consumption in women of childbearing age. This will help to inform education 316 
campaigns necessary to highlight the nutritional value of milk to the diet. 317 
 318 
Iodine and selenium are known to interact, in that selenium is a constituent of the enzymes that 319 
convert T4 to the metabolically active T3 hormone [3]. Previous observational evidence has 320 
suggested that selenium deficiency may hinder efforts to address iodine deficiency [60-62]. In the 321 
present study, baseline median serum selenium concentrations were in the replete range (70-100µg/L) 322 
where most selenoproteins including GPx3 show maximal activity [63]. Although SELENOP is 323 
indicative of the functional selenium body pool, there are no established reference ranges [38]. No 324 
changes in selenium status, as measured by the two biomarkers, were observed between groups as a 325 
result of the increased milk consumption. It is possible that this is owing to participants having 326 
sufficient selenium status at baseline coupled with the fact that the intervention milk was estimated 327 
to provide a minor amount of selenium at 8.5µg/day (14% of the RNI of 60µg/day for adult women) 328 
[31]. In addition, the sample size for this study was calculated for the primary outcome measure, UIC 329 
and as such, there was not sufficient power to reliably examine subgroup effects of the milk 330 
intervention on selenium status. 331 
 332 
In this study we measured UIC from spot urine samples as recommended by WHO as our primary 333 
outcome [34]. We also adjusted for creatinine to remove some of the intra-individual variation in 334 
urine volume. It was unexpected therefore, that we did not observe a significantly higher 335 
iodine:creatinine ratio in the intervention group in conjunction with the UIC. It is possible that this is 336 
owing to a combination of reduced compliance, particularly in the second half of the intervention, 337 
and the possibility that participants in the control group may have unknowingly increased their milk 338 
consumption as a result of taking part in this study.  339 
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Thyroid hormone concentrations were measured as a measure of thyroid function. Serum 340 
concentrations of thyroid hormones are tightly regulated by TSH from the pituitary gland and are 341 
maintained within relatively narrow limits, owing to this tight homeostatic regulation [64]. The milk 342 
intervention had no effect on thyroid hormone concentrations, as anticipated, as almost all participants 343 
had thyroid hormone concentrations within the reference ranges at each time point.  It is believed that 344 
a healthy replete adult has a body store of approximately 15- 20mg iodine, of which the thyroid stores 345 
70- 80%. It is important to consider the possibility that, for individuals with a low iodine status at 346 
baseline, the milk intervention may have repleted intrathyroidal iodine stores, and thereby exerted a 347 
beneficial impact on thyroid function which was not detectable with our range of biomarkers. 348 
 349 
Using data from UK food composition tables, we estimated that the additional 430mL/d of semi-350 
skimmed milk would provide approximately 133µg/d of additional iodine [21]. However, based on 351 
the median iodine concentration measured in the intervention milk (n=22 samples purchased in 352 
Northern Ireland between July and December 2015) this figure was found to be much greater, at 321 353 
µg/d iodine from the additional milk. It is possible that the values in UK food composition tables are 354 
inaccurate owing to a limited analysis of samples, which may have resulted in our projected intake of 355 
133µg/d being underestimated. The overall median milk concentration of 746.1µg/L iodine is 356 
considerably higher than that reported in previous studies for semi-skimmed milk [65, 66, 40] and 357 
the exact reasons for this are not clear from our data. There were no significant differences in the 358 
iodine concentration of intervention milk analyzed over the study period. However, it is widely 359 
known that the iodine content of milk is highly variable as a result of variation in agricultural 360 
practices, soil content and season [8, 17, 67, 68]. An extensive investigation into the factors 361 
contributing to this variation is warranted to more accurately estimate its contribution to population 362 
dietary intakes in the UK and Ireland. It must be taken into account that the iodine concentration of 363 
the intervention milk in this study is specific to the agricultural practices of this region, and that 364 
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different results may be obtained with the consumption of milk of a lower iodine concentration and 365 
indeed, within a different season. 366 
 367 
In the present study participants were provided with and asked to consume 430mL/d of milk. Similar 368 
levels of compliance were reported in a previous milk intervention study [69]. However it is possible 369 
that our use of dietary assessment as a measure of compliance is limited; the participants may not 370 
have consumed the same amount of milk each day. However, our results still suggest that it is possible 371 
to improve iodine status, as measured by UIC, through a relatively modest increase in milk intake. 372 
Further research would be important to investigate the response to milk intervention in participants 373 
stratified by baseline iodine status and powered on the iodine:creatinine ratio.  374 
 375 
This study has demonstrated that a modest increase in consumption of cow’s milk can increase UIC, 376 
a marker of iodine status, in women of childbearing age, a group vulnerable to the effects of iodine 377 
deficiency. Within the context of a public health strategy designed to reduce the prevalence of iodine 378 
deficiency, an increase in milk consumption could represent an important contribution.  379 
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Figure legends 
Figure 1. CONSORT Flow Diagram depicting the flow of participants through the intervention trial 
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Table 1: Baseline characteristics of study participants within each group†   
 
 Control group  
(n= 39) 
Intervention group  
(n= 39) 
P† 
Median (IQR) Median (IQR) 
Age (years)  24 (21-32) 28 (23-33) 0.392 
Height (m) 1.7 (1.6-1.7) 1.7 (1.6-1.7) 0.329 
Weight (kg) 67.2 (59.4-76.9) 68.6 (60.8-75.8) 0.885 
BMI (kg/m2) 24.4 (21.7-29.3) 24.6 (22.1-27.9) 0.822 
UIC (µg/L) 53.2 (34.8-121) 90.5(43.7-132) 0.393 
Iodine:creatinine (µg/g) 80.4 (58.6-110) 70.3 (59.0-116) 0.842 
Serum TSH (mIU/L) 2.1 (1.4-2.5) 1.8 (1.3-2.5) 0.481 
Serum FT3 (nmol/L) 4.9 (4.6-5.3) 5.0 (4.5-5.4) 0.898 
Serum FT4 (pmol/L) 15.1 (14.0-16.4) 15.4 (13.3-17.8) 0.345 
Serum FT3: FT4 ratio 0.3 (0.3-0.4) 0.3 (0.3-0.3) 0.430 
Serum selenium (µg/L) 77.6 (63.9-84.5) 77.3 (70.5-89.6) 0.294 
SELENOP (mg/L) 4.6 (3.9-5.0) 4.7 (4.0-5.3) 0.402 
Estimated milk intake (mL/d) 140 (40-240) 120 (40-200) 0.539 
Values are medians (IQR), n= 78 
IQR= Interquartile Range, BMI= Body Mass Index, UIC= Urinary iodine concentration, TSH= Thyroid stimulating 
hormone, FT3= Free Triiodothyronine, FT4= Free Thyroxine, SELENOP= Selenoprotein P 
† Differences between groups at baseline assessed by Mann Whitney U Test or Independent T-Test 
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Table 2: Iodine status of study participants at baseline, week 6 and 12 
Iodine status measure Time period  Control Group Intervention Group 
P† Median (IQR) Median (IQR) 
UIC (µg/L) 
 
Baseline  0.492             57.6 (36.7-124) 90.5 (43.7-132) 
Week 6 0.005 67.7 (35.1-117) 114 (66.5-181)* 
Week 12 0.026 82.9 (44.9-139) 118 (80.5-207)* 
Change in UIC (µg/L) Baseline – week 6 0.014 0.6 (-30.4-24.0) 35.4 (-10.8-81.8) 
 Week 6 – 12 0.756 1.9 (-20.3-42.4) 7.9 (-35.4-65.4) 
 Baseline – week 12 0.045 -3.8 (-20.9-47.5) 51.6 (-6.8-116) 
     
Iodine:creatinine (µg/g) 
 
Baseline  0.721 81.7 (59.1-111) 70.3 (59.0-116) 
Week 6 0.104 76.9 (53.1-139) 102 (73.9-149)* 
Week 12 0.141 103 (66.9-129) 121 (81.9-165)* 
Change in iodine:creatinine (µg/g) Baseline – week 6 0.061 -4.0 (-19.2-41.4) 36.7 (-9.2-77.2) 
 Week 6 – 12 0.637 4.2 (-16.1-40.1) 13.2 (-28.3-49.6) 
 Baseline – week 12 0.178 12.7 (-12.0-53.4) 29.3 (-16.7-83.9) 
     
Serum TSH (mIU/L) 
 
Baseline  0.481 2.1 (1.4-2.5) 1.8 (1.3-2.5) 
Week 6 0.238 2.3 (1.5-3.0) 1.8 (1.3-2.5) 
Week 12 0.478 1.9 (1.5-2.6) 1.9 (1.4-2.4) 
     
Serum FT3 (nmol/L) 
 
Baseline  0.898 4.9 (4.6-5.8) 5.0 (4.5-5.4) 
Week 6 0.400 5.0 (4.6-5.8) 5.0 (4.4-5.3) 
Week 12 0.938 5.0 (4.6-5.3) 4.9 (4.4-5.5) 
     
Serum FT4 (pmol/L) 
 
Baseline  0.346 15.1 (14.0-16.4) 15.4 (13.3-17.8) 
Week 6 0.935 15.1 (13.8-16.7) 14.8 (13.5-17.1) 
Week 12 0.921 15.3 (13.9-16.7) 15.2 (13.4-16.9) 
     
Serum FT3: FT4 ratio  Baseline  0.430 0.3 (0.3-0.4) 0.3 (0.3-0.3) 
Week 6 0.480 0.3 (0.3-0.4) 0.3 (0.3-0.4) 
Week 12 0.744 0.3 (0.3-0.4) 0.3 (0.3-0.3) 
Values are medians (IQR), n= 78 
IQR= Interquartile Range, UIC= Urinary iodine concentration, TSH= Thyroid stimulating hormone, FT3= Free Triiodothyronine, FT4= Free Thyroxine 
†Differences between groups at each time point assessed by Mann Whitney U Test or Independent T-Test 
*Significantly different from baseline, P<0.05 
 
 
 
 
 
24 
 
 
 
Table 3: Selenium status of study participants at baseline, week 6 and 12 
Selenium status measure Time period P† Control Group  Intervention Group 
Median (IQR) Median (IQR) 
Serum selenium (µg/L) Baseline 0.294 77.6 (63.9-84.5) 77.3 (70.5-89.6) 
Week 6 0.726 75.9 (66.0-85.7) 77.4 (67.5-87.3) 
Week 12 0.934 78.5 (67.7-85.5) 78.6 (67.0-84.4) 
     
SELENOP (mg/L) Baseline 0.702 4.63 (3.86-5.02) 4.61 (3.98-5.27) 
Week 6 0.277 4.61 (3.94-5.17) 4.57 (3.89-5.09) 
Week 12 0.540 4.49 (3.63-5.13) 4.50 (3.81-5.01) 
Values are medians (IQR), n =78 
IQR= Interquartile Range, SELENOP= Selenoprotein P 
†Differences between groups at each time point assessed by Mann Whitney U Test or Independent T-Test 
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Figure 1. 
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 All samples (n=22) July (n=2) August (n=4) September (n=5) October (n=4) November (n=4) December (n=3) P† 
 
Iodine 
(µg/L) 
746.1 
(714.8- 789.9) 
745.2  
(86.2- 745.2) 
745.2 
 (710.0- 780.3) 
723.7  
(702.3- 752.3) 
746.1  
(730.9- 755.4) 
816.1  
(780.5- 836.2) 
717.9  
(659.5- 717.9) 0.153 
Selenium    
(µg/L) 
19.9 
(18.6- 21.0) 
17.3  
(16.4- 17.3) 
19.4  
(17.0- 20.6) 
18.8  
(17.1- 17.9) 
21.4 
(21.1- 21.8) 
20.3  
(19.7- 21.2) 
20.7  
(19.3- 20.7) 0.223 
Values are medians (IQR) 
†Differences between months assessed using one-way ANOVA.  
 
Supplemental Table 1: Iodine and selenium concentration of intervention milk by month of purchase  
 
 
 
 
